Secondary Hypogonadism: How to Identify It in Your Labs and Fix It
Low testosterone with low or normal LH is textbook secondary hypogonadism. Here's how to read your labs, what it means, and why enclomiphene works.
The Two Types of Hypogonadism When testosterone is low, the critical question is: where is the problem? **Primary hypogonadism** -- the testes themselves are failing. LH is high (pituitary is screaming for more testosterone) but the testes cannot respond. Treatment: TRT. **Secondary hypogonadism** -- the problem is upstream. The pituitary is not sending enough LH/FSH signal. The testes are capable of producing testosterone but are not being told to. Treatment: stimulate the axis from the top. The distinction is everything -- because the treatment is completely different.
Reading the Pattern in Your Labs
The classic secondary hypogonadism presentation:
Total Testosterone: Low (under 350 ng/dL). LH: Low-normal (under 4 mIU/mL) or low. FSH: Low-normal or low. Estradiol: Normal or low. SHBG: Variable.
The key is the LH/T relationship. If T is low and LH is low-normal instead of elevated, the problem is at the hypothalamic-pituitary level, not the testes. That is secondary hypogonadism.
Common causes: sleep disruption (shift work, sleep apnea), chronic stress with elevated cortisol, obesity, opioid use, head trauma, hyperprolactinemia, or simply idiopathic age-related HPG axis blunting.
Why Enclomiphene Works
Enclomiphene is a selective estrogen receptor modulator (SERM) -- specifically the trans-isomer of clomiphene, isolated because it carries all the HPG-stimulating benefit without the vision side effects associated with the cis-isomer (zuclomiphene).
Mechanism: Enclomiphene blocks estrogen receptors in the hypothalamus and pituitary. The brain reads this as low estrogen and responds by increasing GnRH, then LH/FSH, then endogenous testosterone production.
It does not replace testosterone. It tells your body to make more of its own.
Critical advantages over TRT:
Typical Protocol
Dose: 12.5-25 mg orally, 3-5 days per week
Form: Capsule (compounding pharmacy)
Monitoring: Recheck testosterone and LH at 6 weeks
Expected response at 6 weeks with 25 mg daily:
What to Monitor in Your Labs
At 6-week follow-up, track:
Total Testosterone -- target 500-900 ng/dL for most men
Free Testosterone -- should improve proportionally
Estradiol (E2) -- enclomiphene raises estrogen too; if E2 climbs above 45-50 pg/mL with symptoms, discuss with prescriber
LH/FSH -- both should rise, confirming the axis is responding
Hematocrit -- unlike TRT, enclomiphene rarely raises hematocrit significantly, but monitor
IGF-1 -- enclomiphene can modestly suppress IGF-1; if using tesamorelin concurrently, track both
Enclomiphene + Tesamorelin: A Powerful Combination
Many secondary hypogonadism presentations also include suboptimal IGF-1 -- often from the same underlying axis blunting (shift work, chronic stress, sleep disruption affect both axes).
Running tesamorelin (GHRH axis) concurrently with enclomiphene (HPG axis) targets two independent systems with zero competition. They work through completely different receptors and pathways.
Track Your Hormone Panel in MyProtocolStack
Enter your baseline Total T, Free T, LH, FSH, Estradiol, and SHBG before starting enclomiphene. Set a 6-week draw reminder. StackAI will analyze the delta -- flagging whether your LH response matches expected, whether E2 needs attention, and whether the protocol is driving you toward optimal range.
If you are not tracking labs, you are not running a protocol. You are guessing.
The information in this article is for educational purposes only. It does not constitute medical advice. Always consult a licensed healthcare provider before starting any protocol.
Written by Ryan -- Founder, MyProtocolStack. Last Updated: April 2026.
Enter your blood work in MyProtocolStack, run StackAI analysis, and get personalized insights based on your actual numbers — not generic charts.
Start Free →